INJ Price Eyes a Breakout to $21 as Cboe Submits a Spot “Staked” ETF Application

Key Points

1. Cboe BZX Exchange filed for a spot 'Canary Staked INJ ETF' on behalf of Canary Capital Group LLC, aiming to bring a staking-enabled INJ fund to the U.S. equities market.

2. The filing aligns with increased ETF interest under a favorable regulatory regime, with the SEC previously opening the door to staking-based ETFs.

3. Injective (INJ) is trading at $14.83, showing bullish momentum with potential for a breakout above $15.97, targeting higher Fibonacci levels.

4. The RSI at 60.36 and MACD in a mild bullish crossover indicate strong buying pressure without being overbought.

5. The ETF filing could act as a catalyst for INJ, with the $18.27–$21.68 zone identified as the next key resistance area.